LOVE TED W Insider Trades

Insider Trading History

Track insider trading activity for LOVE TED W. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Structure Therapeutics
Structure Therapeutics GPCR
Director
Holding Value $1.8M 39,453 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.69M 39,453 shares
$42.93
$45.61
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $3.23M 58,393 shares
Last Trade
Jun 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$254k 4,545 shares
$55.87
$55.34
Gilead Sciences
Gilead Sciences GILD
Director
Holding Value $611k 4,884 shares
Last Trade
Apr 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$639k 4,884 shares
$130.84
$125.05
Gilead Sciences
Gilead Sciences GILD
Director
Holding Value $686k 5,484 shares
Last Trade
Apr 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 1,146 shares
$130.84
$125.05
Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc JAZZ
Director
Holding Value $352k 1,527 shares
Last Trade
Feb 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$289k 1,527 shares
$188.97
$230.25
Structure Therapeutics
Structure Therapeutics GPCR
Director
Holding Value $2.36M 51,804 shares
Last Trade
Jun 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.14M 51,804 shares
$22.10
$45.61
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $2.98M 53,848 shares
Last Trade
May 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 7,614 shares
$32.82
$55.34
Gilead Sciences
Gilead Sciences GILD
Director
Holding Value $851k 6,809 shares
Last Trade
May 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$673k 6,809 shares
$98.90
$125.05
Structure Therapeutics
Structure Therapeutics GPCR
Director
Holding Value $1.53M 33,595 shares
Last Trade
Jun 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.34M 33,595 shares
$39.96
$45.61
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $2.56M 46,234 shares
Last Trade
Jun 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$255k 9,293 shares
$27.46
$55.34
Gilead Sciences
Gilead Sciences GILD
Director
Holding Value $1.58M 12,648 shares
Last Trade
May 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$821k 12,648 shares
$64.92
$125.05
Gilead Sciences
Gilead Sciences GILD
Director
Holding Value $375k 2,996 shares
Last Trade
Feb 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$231k 2,996 shares
$76.96
$125.05
Seagen
Seagen SGEN
Director
Holding Value $0 0 shares
Last Trade
Dec 14, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$468k 2,044 shares
$228.74
$228.74
Seagen
Seagen SGEN
Director
Holding Value $0 0 shares
Last Trade
Dec 14, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$841k 3,676 shares
$228.74
$228.74
Seagen
Seagen SGEN
Director
Holding Value $0 0 shares
Last Trade
Dec 14, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$974k 4,255 shares
$229.00
$228.74
Seagen
Seagen SGEN
Director
Holding Value $0 0 shares
Last Trade
Dec 14, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$792k 3,462 shares
$228.74
$228.74
Seagen
Seagen SGEN
Director
Holding Value $0 0 shares
Last Trade
Dec 14, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.02M 4,460 shares
$228.74
$228.74
Structure Therapeutics
Structure Therapeutics GPCR
Director
Holding Value $3.42M 75,000 shares
Last Trade
Aug 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.38M 75,000 shares
$31.72
$45.61
Royalty Pharma plc
Royalty Pharma plc RPRX
Director
Holding Value $2.04M 36,941 shares
Last Trade
Jun 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$240k 7,747 shares
$30.95
$55.34
Seagen
Seagen SGEN
Director
Holding Value $1.54M 6,748 shares
Last Trade
May 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 2,044 shares
$195.70
$228.74

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up